Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer
Clinical trial NCT03611179 · UNKNOWN
Trial details
- NCT number
- NCT03611179
- Sponsor
- Nada Hassan Salah
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-01
- Primary completion
- 2022-08-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.